Treace Medical Concepts Reports Second Quarter 2026 Financial Results
Treace Medical Concepts, a Nasdaq-listed medical technology company specializing in bunion surgical treatments, reported Q2 2026 revenue of $45.4 million, down 4% year-over-year, with a net loss of $15.9 million. The company reduced cash usage by 57% year-to-date and improved adjusted EBITDA loss slightly. It initiated limited releases of new produ…